Heart failure is a growing problem that is only likely to get worse over the ensuing decades as the baby boomer generation ages and life expectancy increases. Diastolic HF already accounts for about half of all HF and will likely become an even larger percentage of the HF patient cohort because of its higher prevalence in the elderly. At present, we have limited medical options for patients with diastolic HF due to a lack of data from randomized, controlled clinical trials directed at this population. However, several studies are ongoing to identify medications to treat this population. In the meantime, implementing disease management strategies appear to improve the outcomes of this subgroup of HF patients. Consistent with these findings of traditional disease management strategies, an HF management strategy based on continuously monitored intracardiac pressures in HF patients with preserved left ventricular function holds promise as a means to significantly improve patient morbidity and quality of life.
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine